NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 180 filers reported holding NEKTAR THERAPEUTICS in Q2 2016. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $300,000 | +23.0% | 24,457 | +37.9% | 0.08% | +128.6% |
| Q1 2016 | $244,000 | -61.0% | 17,736 | -52.2% | 0.04% | -47.8% |
| Q4 2015 | $625,000 | -81.2% | 37,093 | -86.1% | 0.07% | -79.4% |
| Q2 2015 | $3,327,000 | +649.3% | 265,960 | +622.3% | 0.32% | +755.3% |
| Q3 2014 | $444,000 | -35.1% | 36,822 | -30.9% | 0.04% | -29.6% |
| Q2 2014 | $684,000 | -85.0% | 53,318 | -85.9% | 0.05% | -82.1% |
| Q1 2014 | $4,571,000 | +52.5% | 377,155 | +31.4% | 0.30% | +120.4% |
| Q3 2013 | $2,998,000 | +28.6% | 287,048 | +42.2% | 0.14% | +39.8% |
| Q2 2013 | $2,332,000 | – | 201,929 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
| Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
| Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
| Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
| BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
| First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
| Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
| QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
| Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |